Tracking STOK? Get live short interest, options flow, and signals on ORTEX.Sign up free →
ST
Stoke Therapeutics, Inc. (STOK) short interest & options flow
NASDAQStoke Therapeutics heads into its August 7 earnings print as one of the more heavily shorted small-cap biotechs in the RNA medicine space, with positioning that has shifted sharply more bearish over the past month. Short sellers have been building aggressively. Short interest has climbed to 27.5% of the free float — up 33% in a month and nearly 14% in the last week alone, with the…
$27.45+1.70% 1d+3.94% 1w+7.14% 1mClose: 4 Nov 2026
- Market cap
- $1.80B
- Next earnings
- 9 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.
Key data as of 5 Nov 2026
STOK news and analysis
RSSNo long-form analysis yet for STOK. Pulse alerts and the live data picture are available on ORTEX.
Open STOK on ORTEX →Want the live picture for STOK?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for STOK — free to start on ORTEX.
Sign up for free →Open STOK on ORTEX